Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study

BACKGROUND: Microencapsulated sodium butyrate (MSB) has been previously associated with anti-inflammatory and regenerative properties regarding large bowel mucosa. We aimed to examine a role of MSB in patients with diverticulosis, hypothesizing its potential for reduction of diverticulitis episodes...

Descripción completa

Detalles Bibliográficos
Autores principales: Krokowicz, Lukasz, Stojcev, Zoran, Kaczmarek, Bartosz Filip, Kociemba, Wojciech, Kaczmarek, Elżbieta, Walkowiak, Jaroslaw, Krokowicz, Piotr, Drews, Michal, Banasiewicz, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936115/
https://www.ncbi.nlm.nih.gov/pubmed/24343275
http://dx.doi.org/10.1007/s00384-013-1807-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936115/
https://www.ncbi.nlm.nih.gov/pubmed/24343275
http://dx.doi.org/10.1007/s00384-013-1807-5

Ejemplares similares